Posted by qbsbrown on January 14, 2006, at 3:37:57
In reply to Why isn't CYMBALTA as popular as one would think?, posted by qbsbrown on January 14, 2006, at 3:28:25
Guess i was wrong.
"Projections are bullish for Lilly's (Research) Cymbalta, which entered the market as an antidepressant in August, 2004, and was also approved in September of that year as a treatment for diabetic peripheral neuropathic pain. The drug's sales during the first nine months of 2005 totaled $451 million. Ryan, the Deutsche Bank analyst, wrote that Cymbalta is off to a "solid launch," and she projected $1 billion in annual sales by 2007. Both Suntrust Robinson Humphrey analyst Hazlett and Bear Stearns' Boris project that Cymbalta could reach $3 billion in annual sales by the end of the decade, bringing it neck in neck with competitor Lexapro."
poster:qbsbrown
thread:598954
URL: http://www.dr-bob.org/babble/20060108/msgs/598955.html